ELEKTA, INC.

Manufacturer of cancer care medical devices, software, and therapy planning products

Filings
47
Clients
1
Total Income
Years Active
2014–2026

Filings

Year Client Period Income Expenses Doc
2026 ELEKTA, INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$70,000
2025 ELEKTA, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$30,000
2024 ELEKTA, INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$39,000
2024 ELEKTA, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$39,000
2024 ELEKTA, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$39,000
2024 ELEKTA, INC. 2nd Quarter (Apr 1 - June 30)
AMENDED
2023 ELEKTA, INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Termination
$50,000
2023 ELEKTA, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$50,000
2023 ELEKTA, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$60,000
2023 ELEKTA, INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$60,000
Page 1 of 5  ·  47 filings Next

Clients Represented

ClientFilingsTotal Income
ELEKTA, INC. 47

Lobbyists

NameDisclosed Prior Position
COOKAB HASHEMI Senior Director, Government Affairs, Policy & Reimbursement
DESIREE KENNEDY
CARA SANTILLO
ROBERT D THOMAS

Affiliated Organizations

ELEKTA
Atlanta, GA, US